NCCAM Competing Renewal Submitted on September 12, 2012
Read More9th Annual Agi Hirshberg Symposium on Pancreatic Cancer. January 26, 2013
Saturday, January 26, 2013 9:30 a.m. – 2:30 p.m. UCLA Faculty Center PROGRAM SCHEDULE FOR PATIENT AND FAMILY SESSION ADVANCES IN PANCREATIC CANCER MANAGEMENT 9:30 – 9:45 a.m. Welcome and Opening Remarks Agi Hirshberg Founder & CEO Hirshberg Foundation for Pancreatic Cancer Research 9:45 – 10:00 a.m. Remarks from the Dean...
Read MoreInhibition of Glycogen Phosphorylation Induces Changes in Cellular Proteom and Signaling Pathways in MIA Pancreatic Cancer Cells
Objectives: Novel quantitative proteomic approaches were used to study the effects of inhibition of glycogen phosphorylase on proteome and signaling pathways in MIA PaCa-2 pancreatic cancer cells. Methods: We performed quantitative proteomic analysis in MIA PaCa-2 cancer cells treated with a stratified dose of CP-320626 (5-chloro-1H-indole-2-carboxylic acid...
Read More8th Annual Agi Hirshberg Symposium on Pancreatic Cancer. January 31, 2012
JANUARY 31, 2012 This year’s meeting was held at the UCLA Faculty Center on January 31, 2012 with the support of the unrestricted educational grants from Amgen, Genetech and Celgene. We had participants from regional and national scientists and physicians as well as patients and family support groups. The meeting was opened by Ms. Agi Hirshberg, CEO and founder of the Hirshberg...
Read More